Clinical Trial Update: Early Serum Infliximab Levels in Severe Ulcerative Colitis. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on infliximab levels in severe ulcerative colitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease | Phase 1 | Status: COMPLETED